Skip to main content

Carolina Campos Martinez

Predoctoral Researcher at the Liver Diseases - Viral Hepatitis Research group. Bachelor's degree in Biotechnology and MSc in Translational Biomedical Research by the Vall d'Hebron Institute of Research Fundation. Currently working as a PhD Student at the Liver diseases-Viral hepatitis research group and studying at the PhD program of Biochemistry, Molecular Biology and Biomedicine of Universitat Autònoma de Barcelona. My studies are focused on the evolution of viral quasispecies of SARS-CoV-2 in the most prevalent variants in Barcelona city over the pandemics, thanks to next generation sequencing (MiSeq and Nextseq2000 Illumina platforms), and how these viral quasispecies are involved with clinical and epidemiological purposes.

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Carolina Campos Martinez

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Predoctoral Researcher at the Liver Diseases - Viral Hepatitis Research group. Bachelor's degree in Biotechnology and MSc in Translational Biomedical Research by the Vall d'Hebron Institute of Research Fundation. Currently working as a PhD Student at the Liver diseases-Viral hepatitis research group and studying at the PhD program of Biochemistry, Molecular Biology and Biomedicine of Universitat Autònoma de Barcelona. My studies are focused on the evolution of viral quasispecies of SARS-CoV-2 in the most prevalent variants in Barcelona city over the pandemics, thanks to next generation sequencing (MiSeq and Nextseq2000 Illumina platforms), and how these viral quasispecies are involved with clinical and epidemiological purposes.

I studied a Biotechnology degree at the Rovira i Virgili University in Tarragona, Spain. I followed my training during an internship at the Liver Diseases - Viral Hepatitis from VHIR, leaded by Dr. Josep Quer. Finally, I did the TFG in collaboration with Dr. Quer's group which was named "Características genéticas y variabilidad del SARS-CoV-2, agente causal de la COVID-19"

Afterwards, I studied the Traslational Biomedical Research Master by the VHIR and the Universitat Autònoma de Barcelona (UAB), where I worked as liscenced technician at the Liver Diseases - Viral Hepatitis research group. During this internship at Vall d'Hebron, I wrote my TFM named as "SARS-CoV-2: study of solubility of spike truncated protein (S1) and ongoing viral adaptation in new emerging variants". Furthermore, I worked as an active participant in several competitive projects related to the genomic study of Hepatitis C Virus (HCV) and SARS-CoV-2 variability.


Currently I keep working at the VHIR as PhD student of the Biochemistry, Molecular Biology and Biomedicine PhD Program from the UAB at the Liver Diseases - Viral Hepatitis research group. My PhD thesis is focused on the study of expression, localization and solubility in cell culture of the spike truncated protein of SARS-CoV-2 formed merely by the subunit 1. In addition to the in vitro research, I also study the variability of S gen in different SARS-CoV-2 variants and the adaptation trough human population following the depp-sequencing methodology, thanks to Next Generation Sequencing (NGS) techniques.

Projects

Beca VHIR PhD

IP: Josep Quer Sivila
Collaborators: Sira Rodrigo Bosch, Laia Perez Lasarte, Carolina Campos Martinez
Funding agency: Fundació Institut de Recerca HUVH
Funding: 69188.74
Reference: VPHD/CAROLINA_C
Duration: 01/04/2023 - 31/03/2026

Estudio de quasispecies por metagenómica en neuropatías asociadas a virus por secuenciación masiva de nueva generación.

IP: Josep Quer Sivila
Collaborators: Sergi Colomer Castell, Marta Ibañez Lligoña, Lluís Viladomiu Catà, Damir Garcia Cehic, Maria Piñana Moro, Pablo Gabriel Medina, Arnau Llauradó Gayete, Carolina Campos Martinez, Alejandra Gonzalez Sánchez
Funding agency: Instituto de Salud Carlos III
Funding: 292820
Reference: PI22/00258
Duration: 01/01/2023 - 31/12/2025

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Malalties hepàtiques, Maria Buti Ferret, Montserrat Gomez Perez, Malalties hepàtiques, Judit Vico Romero, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Daniel Martinez Vazquez, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, Malalties hepàtiques, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano, Malalties hepàtiques
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

Miquel Masachs Peracaula

Miquel Masachs Peracaula

Read more
Marta Perez  Peña

Marta Perez Peña

Predoctoral researcher
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.